David HU, Beike Biotechnology: China lags behind in stem-cell market development

In a detailed analysis of the Chinese situation, he deplores the gap between MOST-supported R&D and the regulations issued by the Ministry of Health, and expresses expectations that his situation will change in the upcoming new 5 years plan.

China Bio news release, March 18, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny